Introduction
Schizophrenia – a disorder affecting approximately 1% of the population – is characterized by profound disturbances in perception, thought, and self-awareness. Clinical insight deficits are prevalent, with between one-half and four-fifths of patients unable to recognize psychotic experiences as symptoms or acknowledge the need for treatment, predicting poorer medication adherence and functional outcomes (Lincoln, Lüllmann, & Rief, Reference Lincoln, Lüllmann and Rief2007).
Insight itself, however, is not a unitary construct (Konsztowicz, Schmitz, & Lepage, Reference Konsztowicz, Schmitz and Lepage2018). Contemporary models differentiate between clinical insight – illness acknowledgment, symptom relabeling, and recognition of treatment necessity – and cognitive insight, underpinned primarily by self-reflection, the ability to critically evaluate one’s interpretations and beliefs (David, Reference David1990; Xu et al., Reference Xu, Zhang, Wang, Wei, Cui, Qian and Wang2021). Low self-reflectiveness, especially in conjunction with elevated self-certainty, consistently predicts poorer clinical insight (Cooke et al., Reference Cooke, Peters, Fannon, Aasen, Kuipers and Kumari2010), indicating that self-reflection is necessary but insufficient alone for achieving full insight.
Critically, autobiographical memory anchors personal identity by providing vivid memories that shape the coherent sense of self (Bréchet, Reference Bréchet2022). Extending from this foundation, mental time travel (MTT) allows individuals to vividly re-experience past events and imagine detailed future scenarios (Tulving, Reference Tulving1985). Meta-analytic findings highlight substantial impairments in episodic memory specificity and future simulation abilities across stages of schizophrenia (Fornara, Papagno, & Berlingeri, Reference Fornara, Papagno and Berlingeri2017). Such deficits undermine narrative coherence and future-directed planning, both essential components for recognizing illness and taking informed action (Mavrogiorgou et al., Reference Mavrogiorgou, Thomaßen, Pott, Flasbeck, Steinfath and Juckel2022; Stanghellini et al., Reference Stanghellini, Ballerini, Presenza, Mancini, Raballo, Blasi and Cutting2016).
Converging neuroimaging evidence underscores a notable overlap between the neural circuits supporting MTT – particularly the default-mode and ventromedial prefrontal networks – and those engaged during self-reflection and insight processing (Lee, Parthasarathi, & Kable, Reference Lee, Parthasarathi and Kable2021; Østby et al., Reference Østby, Walhovd, Tamnes, Grydeland, Westlye and Fjell2012).
Because most available studies are cross-sectional, links between MTT and insight are interpreted as associations, and reverse or bidirectional explanations remain plausible.
This theory-driven narrative review synthesizes clinical, cognitive, and neurobiological evidence available up to May 2025 to elucidate the relationship between MTT and insight deficits in schizophrenia. It is proposed that impairments in MTT represent a fundamental yet understudied candidate mechanism of poor insight. By integrating existing evidence, the review highlights mechanistic pathways linking MTT, self-reflection, and insight, explores therapeutic implications, and outlines future research directions necessary to clarify this complex interplay.
Methods – research strategy
Databases searched were PubMed, PsycINFO, Web of Science, and Scopus from inception to May 31, 2025. Search strings combined terms for mental time travel (autobiographical memory specificity, episodic future thinking, temporal horizon) AND insight (clinical, cognitive) AND schizophrenia/psychosis. Inclusion criteria were peer-reviewed human studies reporting ≥1 MTT measure and an insight outcome; exclusions were case reports, narrative reviews, and non-English articles.
Conceptual foundations
Clinical and cognitive insight
Early models treated insight in schizophrenia as a single construct, but extensive research indicates at least two distinct facets. Clinical insight involves acknowledging mental illness, identifying psychotic experiences as pathological, and recognizing the need for treatment (Lysaker et al., Reference Lysaker, Chernov, Moiseeva, Sozinova, Dmitryeva, Alyoshin and Kostyuk2021). It is typically measured using clinician-rated tools such as the Schedule for the Assessment of Insight – Expanded (SAI-E) and Scale to Assess Unawareness of Mental Disorder (SUMD) (Amador & Kronengold, Reference Amador, Kronengold, Amador and David2004; David, Buchanan, Reed, & Almeida, Reference David, Buchanan, Reed and Almeida1992).
Cognitive insight reflects a metacognitive stance toward personal beliefs. Beck and colleagues developed the Beck Cognitive Insight Scale (BCIS), which assesses Self-Reflectiveness (the tendency to question one’s interpretations) and Self-Certainty (confidence in one’s judgments) (Beck et al., Reference Beck, Baruch, Balter, Steer and Warman2004). Lower self-reflectiveness, especially when paired with higher self-certainty, reliably predicts poorer clinical insight, increased delusional conviction, and reduced medication adherence (Engh et al., Reference Engh, Friis, Birkenaes, Jónsdóttir, Ringen, Ruud and Andreassen2007; Pedrelli et al., Reference Pedrelli, McQuaid, Granholm, Patterson, McClure, Beck and Jeste2004; Riggs, Grant, Perivoliotis, & Beck, Reference Riggs, Grant, Perivoliotis and Beck2012). Thus, self-reflection emerges as necessary but insufficient for complete insight.
Differential links to MTT. In this review, clinical insight refers to clinician-rated awareness of illness/symptoms/need for treatment (e.g., SAI-E, SUMD), whereas cognitive insight refers to metacognitive self-evaluation (e.g., BCIS Self-Reflectiveness and Self-Certainty) (Beck et al., Reference Beck, Baruch, Balter, Steer and Warman2004). Where studies reported both, mental time travel (MTT) measures tended to show more consistent associations with clinical insight than with cognitive insight, although BCIS Self-Reflectiveness often aligns with greater episodic specificity and future-event detail (Beck et al., Reference Beck, Baruch, Balter, Steer and Warman2004).
Relation to metacognition. Cognitive insight, operationalized by the Beck Cognitive Insight Scale (BCIS), reflects a metacognitive appraisal of one’s own interpretations – indexed by Self-Reflectiveness and Self-Certainty (Beck et al., Reference Beck, Baruch, Balter, Steer and Warman2004). Metacognition is a broader construct that includes self-reflectivity and the ability to use that understanding to guide behavior (mastery) and to take perspectives beyond the self (decentration), as indexed by instruments such as the Metacognition Assessment Scale–Abbreviated (MAS-A) (Lysaker et al., Reference Lysaker, Carcione, Dimaggio, Johannesen, Nicolò, Procacci and Semerari2005; Lysaker et al., Reference Lysaker, Chernov, Moiseeva, Sozinova, Dmitryeva, Alyoshin and Kostyuk2021; Semerari et al., Reference Semerari, Carcione, Dimaggio, Falcone, Nicolò, Procacci and Alleva2003). Thus, cognitive insight overlaps with the self-reflective facet of metacognition but does not encompass other metacognitive capacities (e.g., mastery), which have shown independent associations with clinical insight (Bröcker et al., Reference Bröcker, Bayer, Stuke, Giemsa, Heinz, Bermpohl and Montag2017; Lysaker et al., Reference Lysaker, Carcione, Dimaggio, Johannesen, Nicolò, Procacci and Semerari2005).
Autobiographical memory and self-reflection
A coherent sense of self is supported by a reservoir of autobiographical memories (AM), encoding details of what happened, the context in which events occurred, and their significance for personal goals. Vivid, detailed recollections serve as reference points for evaluating current beliefs, imagining counterfactual alternatives, and updating self-knowledge (Fivush, Reference Fivush2011). In schizophrenia, AM is often characterized by ‘over-generalization,’ with patients recalling events only in broad, gist-like terms that lack specific temporal and spatial details – a pattern linked to impairments in executive function and affect regulation (Berna et al., Reference Berna, Göritz, Schröder, Martin, Cermolacce, Allé, Danion, Cuervo-Lombard and Moritz2016; Herold, Lässer, & Schröder, Reference Herold, Lässer and Schröder2023; Mediavilla et al., Reference Mediavilla, López-Arroyo, Gómez-Arnau, Wiesepape, Lysaker and Lahera2021). Because self-reflection fundamentally relies on detailed personal evidence, a compromised AM store restricts the ability to reality-test psychotic interpretations and integrate current experiences into a coherent life narrative.
Mental time travel (MTT)
Mental time travel (MTT) is the capacity to vividly re-experience past events and pre-experience plausible future scenarios by flexibly recombining episodic details into coherent mental scenes (Suddendorf & Corballis, Reference Suddendorf and Corballis2007). Experimental paradigms reveal three consistent deficits in schizophrenia. First, during episodic memory tasks such as the Autobiographical Interview, patients generate significantly fewer internal details (who was present, what occurred, where, and when) compared to controls, despite similar overall verbosity (Berna, Potheegadoo, et al., Reference Berna, Potheegadoo, Aouadi, Ricarte, Allé, Coutelle, Boyer, Cuervo-Lombard and Danion2016; Danion, Huron, Vidailhet, & Berna, Reference Danion, Huron, Vidailhet and Berna2007). Second, in future simulation paradigms like Scene Construction or Prospective Thinking tasks, patients typically produce vague, generic, and less vivid imagined futures, lacking concrete goals (e.g., ‘I might do something outside’) compared with detailed, goal-oriented scenarios offered by controls (e.g., ‘Next Saturday I’ll meet Tom at the café at 2 p.m. to plan our project’) (Raffard et al., Reference Raffard, D’Argembeau, Lardi, Bayard, Boulenger and Van Der Linden2009; Raffard et al., Reference Raffard, D’Argembeau, Lardi, Bayard, Boulenger and Van der Linden2010). Third, temporal-horizon assessments such as the Temporal-Extension Mental Time Travel (TEMT) task indicate a marked ‘foreshortened future’ bias, with patients typically envisioning only the near-term future (days or weeks ahead), whereas controls project months or years ahead; a recent meta-analysis confirms a moderate-to-large pooled effect for this narrowed projection (Amadeo et al., Reference Amadeo, Escelsior, Esposito, Inuggi, Versaggi, Marenco and Gori2024; Casadio et al., Reference Casadio, Patané, Candini, Lui, Frassinetti and Benuzzi2024). Together, these findings suggest that schizophrenia involves impaired event construction in both past and future contexts and a narrowed temporal scope, limiting the autobiographical reference points necessary for accurate self-reflection and insight.
Temporal horizon and valuation
Temporal horizon refers to the span of time individuals can imagine and use to guide decisions, with a broader horizon supporting better anticipation of future outcomes and greater willingness to wait for delayed outcomes (Jones, Landes, Yi, & Bickel, Reference Jones, Landes, Yi and Bickel2009). In schizophrenia, both experimental and clinical studies indicate a ‘foreshortened future’ – difficulty extending prospection beyond the near term – and steeper delay discounting (greater preference for immediate rewards) (Jones et al., Reference Jones, Landes, Yi and Bickel2009). These alterations co-occur with documented deficits in episodic memory and future simulation, processes that support prospection and valuation of delayed outcomes (Chen et al., Reference Chen, Liu, Cui, Wang, Chen, Li and Chan2016).
Outside psychosis, episodic future thinking (EFT) – actively imagining specific future scenarios – reliably reduces delay discounting, increasing the value placed on delayed outcomes; meta-analyses show a robust overall effect, with positively valenced future cues producing the largest reductions (Rung & Madden, Reference Rung and Madden2018; Ye et al., Reference Ye, Ding, Cui, Liu, Jia, Qin and Wang2022). Although psychosis-specific EFT trials are scarce, schizophrenia shows consistent deficits in autobiographical/episodic memory and future simulation, processes that support prospection (Chen et al., Reference Chen, Liu, Cui, Wang, Chen, Li and Chan2016; Heerey, Matveeva, & Gold, Reference Heerey, Matveeva and Gold2011). Temporal-processing abnormalities are also documented in psychosis (e.g., widened audiovisual temporal-binding windows), underscoring a broader timing disturbance (Amadeo et al., Reference Amadeo, Escelsior, Esposito, Inuggi, Versaggi, Marenco and Gori2024; Stevenson et al., Reference Stevenson, Park, Cochran, McIntosh, Noel, Barense, Ferber and Wallace2017). A shortened temporal horizon compresses the window over which costs and benefits are evaluated, amplifying delay discounting and biasing choices toward immediate relief over delayed benefit. In schizophrenia, this specifically weakens the ‘need for treatment’ component of clinical insight, because future gains from medication or therapy are devalued relative to present inconvenience or side-effects. Together, these findings support a mechanistic bridge: expanding future simulation could improve appraisal of delayed treatment benefits – a computation relevant to the ‘need for treatment’ dimension of clinical insight and correction of poor illness awareness.
Metacognition: the integrative hub
Metacognition refers to the ability to reflect on, monitor, and flexibly manage one’s own and others’ mental states. In schizophrenia, broad metacognitive impairments – especially in self-reflectivity (understanding one’s own thoughts) and mastery (using that understanding to respond adaptively) – are now considered core features of the disorder (Flavell, Reference Flavell1979). These deficits predict poorer clinical and cognitive insight, independent of neurocognitive performance or symptom severity, and have been shown to partially mediate the relationship between overgeneral autobiographical memory and reduced illness awareness (Davies & Greenwood, Reference Davies and Greenwood2020; Mediavilla et al., Reference Mediavilla, López-Arroyo, Gómez-Arnau, Wiesepape, Lysaker and Lahera2021). In this framework, cognitive insight (BCIS) is treated as a metacognitive appraisal subdomain (self-reflection/self-certainty), whereas metacognition additionally includes mastery and related capacities not captured by BCIS, helping to explain distinct patterns of association with clinical insight.
Neuroimaging studies reveal that metacognitive self-reflection recruits the medial prefrontal cortex, precuneus, and posterior cingulate – key nodes within the default-mode network (DMN), a system in the brain that becomes active during rest, self-focused thinking, remembering the past, and imagining the future (Buckner, Andrews-Hanna, & Schacter, Reference Buckner, Andrews-Hanna and Schacter2008). Disruptions in this network are common in schizophrenia and may explain overlapping problems in metacognition, autobiographical memory, and mental time travel. These same regions also support MTT and show functional disruption in patients with poor insight (Fuentes-Claramonte et al., Reference Fuentes-Claramonte, Martin-Subero, Salgado-Pineda, Santo-Angles, Argila-Plaza, Salavert and Salvador2019; Holt et al., Reference Holt, Cassidy, Andrews-Hanna, Lee, Coombs, Goff and Moran2011; Shan et al., Reference Shan, Liao, Ou, Ding, Liu, Chen and He2020). Thus, metacognition may act as a central mechanism through which impoverished mental time travel simulations (due to degraded autobiographical memory) fail to transform into accurate, treatment-relevant insight.
Behavioral evidence: how mental-time-travel performance tracks with insight
Cross-sectional findings in established illness
Since 2005, around two dozen studies have shown that poorer performance on mental time travel tasks – such as episodic past recall (e.g., Autobiographical Interview), future-event simulation (e.g., Scene Construction, Future-Event Fluency), and temporal-horizon tasks – is consistently linked to lower insight in individuals with schizophrenia. After controlling for factors like IQ and negative symptoms, correlations between MTT measures and insight typically fall in the small-to-moderate range (r ≈ 0.30–0.45) (Barry, Hallford, Del Rey, & Ricarte, Reference Barry, Hallford, Del Rey and Ricarte2020; Berna et al., Reference Berna, Göritz, Schröder, Martin, Cermolacce, Allé, Danion, Cuervo-Lombard and Moritz2016; MacDougall et al., Reference MacDougall, McKinnon, Herdman, King and Kiang2015; Raffard et al., Reference Raffard, D’Argembeau, Bayard, Boulenger and Van der Linden2010). This relationship holds across diverse samples, including outpatient and forensic populations, and is consistent across multiple measures of insight (e.g., SUMD, SAI-E, BCIS), regardless of whether patients primarily show positive or negative symptoms. When both components were analyzed, associations between MTT measures and clinical insight were generally stronger and more consistent than those with cognitive insight, although higher Self-Reflectiveness frequently accompanied greater autobiographical/future specificity.
Together, these findings suggest that MTT impairments are not just secondary effects or side issues – they are closely tied to the core clinical problem of poor illness awareness.
Early-course and high-risk cohorts
Emerging evidence suggests that the link between MTT and insight is present early in the course of illness and even in individuals at elevated risk. In a study of first-episode patients, Potheegadoo et al. found that distorted perceptions of how close or distant past events felt – along with reduced episodic detail – explained about 11% of the variance in SUMD insight scores (r = .31) (Potheegadoo, Cuervo-Lombard, Berna, & Danion, Reference Potheegadoo, Cuervo-Lombard, Berna and Danion2012). Among high-schizotypy undergraduates, Hazan et al. reported that vague, goal-sparse future narratives and low perceived control in turning-point memories predicted weaker perceived need for help (r = −.28) on the Insight and Treatment Attitudes Questionnaire – ITAQ (Hazan, Reese, & Linscott, Reference Hazan, Reese and Linscott2019).
In an early-course clinical sample, Allé et al. found that fragmented narratives across past and future life stories were linked to higher unawareness of illness (β = −.33) (Allé et al., Reference Allé, d’Argembeau, Schneider, Potheegadoo, Coutelle, Danion and Berna2016). Similarly, Barry et al. showed that in patients within 2 years of diagnosis, generating more specific future events predicted higher BCIS Self-Reflectiveness (r = .39) and lower Self-Certainty (r = −.35) (Barry et al., Reference Barry, Hallford, Del Rey and Ricarte2020). Even in non-clinical populations, less vivid and less detailed ‘delusion-like’ memories predicted stronger conviction in those thoughts (β = −.33) (Berna et al., Reference Berna, Potheegadoo, Aouadi, Ricarte, Allé, Coutelle, Boyer, Cuervo-Lombard and Danion2016). Together, these findings suggest that impoverished scene construction, narrowed time horizons, and disrupted narrative continuity are not late effects of chronic schizophrenia, but early cognitive vulnerabilities that impair the development of accurate insight.
Mediation and moderation analyses
Indirect evidence for metacognitive mediation
Although no published study has yet modelled the full chain ‘MTT detail → metacognition → clinical insight,’ converging evidence supports each link in the pathway. First, reduced autobiographical or episodic-memory specificity is consistently associated with weaker metacognitive-self capacities (Mediavilla et al., Reference Mediavilla, López-Arroyo, Gómez-Arnau, Wiesepape, Lysaker and Lahera2021), Second, lower metacognitive scores, in turn, predict poorer clinical insight (Lungu et al., Reference Lungu, Lungu, Ciobîcă, Balmus, Boloș, Dobrin and Luca2023; Martiadis et al., Reference Martiadis, Pessina, Raffone, Iniziato, Martini and Scognamiglio2023). For example, in individuals with attenuated psychotic symptoms, Berna et al. (Reference Berna, Potheegadoo, Aouadi, Ricarte, Allé, Coutelle, Boyer, Cuervo-Lombard and Danion2016) found that fewer autobiographical-memory details correlated with higher Self-Disorder scores – a construct that substantially overlaps the Self-Reflectivity dimension of the MAS-A (Berna et al., Reference Berna, Göritz, Schröder, Martin, Cermolacce, Allé, Danion, Cuervo-Lombard and Moritz2016). Similarly, studies in first-episode psychosis show that impaired metacognitive mastery is linked to diminished insight, whereas higher mastery scores independently predict better illness awareness (Leonhardt et al., Reference Leonhardt, Vohs, Bartolomeo, Visco, Hetrick, Bolbecker and O’Donnell2020; Vohs et al., Reference Vohs, Lysaker, Liffick, Francis, Leonhardt, James and Breier2015). Taken together, these findings strongly suggest a mediation pathway, but a definitive test that incorporates a genuine MTT task (e.g., Scene Construction, TEMT) alongside standardized metacognition and insight measures remains an important research priority.
Symptom moderators
Emerging evidence suggests that the association between autobiographical memory (AM) specificity and clinical insight may be particularly pronounced in individuals with prominent negative symptoms. Meta-analyses and large-scale reviews consistently show that people with schizophrenia recall fewer specific autobiographical memories than healthy controls, with moderate-to-large effect sizes for memory specificity and richness of detail (Berna, Potheegadoo, et al., Reference Berna, Potheegadoo, Aouadi, Ricarte, Allé, Coutelle, Boyer, Cuervo-Lombard and Danion2016; H. Zhang et al., Reference Zhang, Wang, Hu, Zhu, Zhang, Wang and Li2019; Y. Zhang et al., Reference Zhang, Kuhn, Jobson and Haque2019). Recent studies further indicate that AM performance is significantly correlated with negative symptoms, including apathy, in chronic schizophrenia. Specifically, one investigation found that the extent of negative symptoms may explain a substantial portion of AM deficits, with AM specificity and vividness both reduced in patients exhibiting higher negative symptom severity (Herold et al., Reference Herold, Lässer and Schröder2023). Although most research confirms a general link between diminished AM specificity and poorer insight, these findings imply that in negative-symptom-dominant subgroups, deficits in autobiographical memory may have a more substantial impact on self-awareness and illness recognition, thereby amplifying the coupling between memory specificity and clinical insight (Herold et al., Reference Herold, Lässer and Schröder2023). This pattern underscores the importance of considering symptom profiles when examining cognitive mechanisms underlying insight in schizophrenia.
Affective and trauma moderators
Mood and life-history factors appear to shape how strongly autobiographical-memory deficits translate into poor insight. Several studies show that higher depressive symptoms are paradoxically associated with better illness awareness (Lincoln et al., Reference Lincoln, Lüllmann and Rief2007; Lysaker et al., Reference Lysaker, Pattison, Leonhardt, Phelps and Vohs2018; Weiss-Cowie, Verhaeghen, & Duarte, Reference Weiss-Cowie, Verhaeghen and Duarte2023), a pattern often interpreted as ‘depressive realism’ (Moore & Fresco, Reference Moore and Fresco2012). By contrast, childhood-trauma exposure has been linked both to over-general autobiographical memory and to diminished clinical insight (Berenz et al., Reference Berenz, Vujanovic, Rappaport, Kevorkian, Gonzalez, Chowdhury, Dutcher, Dick, Kendler and Amstadter2018; Irwin, Green, & Marsh, Reference Irwin, Green and Marsh1999; Kalantar-Hormozi & Mohammadkhani, Reference Kalantar-Hormozi and Mohammadkhani2024). More recent work in serious mental-illness samples indicates that PTSD symptom severity co-occurs with fragmented personal memories (Hardy, Reference Hardy2017). Although no published study has yet tested these variables as formal moderators of an MTT and insight pathway, the converging evidence suggests that dysphoric mood may attenuate – and trauma history may amplify – the cognitive route to impaired insight.
Higher depressive symptoms are often linked to greater clinical insight in schizophrenia (the ‘insight paradox’), plausibly via demoralization/internalized stigma and rumination-driven negative self-appraisal – pathways that raise illness acknowledgment independently of MTT; consequently, dysphoria can attenuate observed MTT–insight correlations (Belvederi Murri et al., Reference Belvederi Murri, Respino, Innamorati, Cervetti, Calcagno, Pompili and Amore2015; Cavelti et al., Reference Cavelti, Kvrgic, Beck, Rüsch and Vauth2012; Lysaker, Gagen, Moritz, & Schweitzer, Reference Lysaker, Gagen, Moritz and Schweitzer2018).
Interim synthesis – strengths, limits, and open questions
Behavioral findings converge on a plausible chain – impoverished MTT performance → weaker metacognitive monitoring → poorer clinical insight – and show that delusional conviction, prominent negative symptoms, and trauma intensify this pathway, whereas depressive mood may blunt it. This proposed pathway is depicted in Figure 1. (Balzan et al., Reference Balzan, Mattiske, Delfabbro, Liu and Galletly2019; Faith et al., Reference Faith, Lecomte, Corbière, Francoeur, Hache-Labelle and Lysaker2020; Luther et al., Reference Luther, Bonfils, Fischer, Johnson-Kwochka and Salyers2020; Vohs et al., Reference Vohs, Lysaker, Francis, Hamm, Buck, Olesek and Breier2014). Yet three key gaps remain: (i) MTT-specific mechanisms are still opaque. Most studies measure global metacognition; only a handful deploy dedicated MTT tasks (scene construction, temporal-horizon) when examining insight. Whether the episodic component uniquely drives insight loss is therefore unproven (Lysaker, Gagen, et al., Reference Lysaker, Gagen, Moritz and Schweitzer2018). (ii) Trauma’s role is only indirectly supported. Childhood adversity fragments autobiographical memory and weakens metacognition, but no published work has tested trauma × MTT or trauma × insight interactions in a single model (Aharon Biram et al., Reference Aharon Biram, Horesh, Tuval-Mashiach and Hasson-Ohayon2024; Takarangi, Smith, Strange, & Flowe, Reference Takarangi, Smith, Strange and Flowe2017). (iii) Causality is unknown. Evidence is almost entirely cross-sectional, so we cannot determine whether MTT deficits cause poor insight, whether poor insight erodes MTT, or whether both stem from a shared neural factor such as default-mode dysconnectivity – an idea awaiting longitudinal or interventional tests (Jun, Miao, & Ying, Reference Jun, Miao and Ying2025). In sum, therapies that jointly enhance episodic specificity and metacognitive mastery (e.g., Metacognitive Reflection and Insight Therapy (MERIT), episodic-future-thinking modules) remain the best-supported clinical options (de Jong et al., Reference de Jong, van Donkersgoed, Timmerman, Aan Het Rot, Wunderink, Arends, van Der Gaag, Aleman, Lysaker and Pijnenborg2019; Martin et al., Reference Martin, Bullock, Fiszdon, Stacy, Martino, James and Lysaker2023), but definitive studies – longitudinal, experimental, and trauma-stratified – are still needed to confirm the direction and specificity of the MTT → metacognition → insight pathway.

Figure 1. Conceptual pathway from autobiographical memory to clinical insight in schizophrenia.
Neuroimaging and neurophysiology
Task-based fMRI: overlapping circuitry for MTT and insight
Core brain regions jointly implicated in MTT and insight—particularly the medial prefrontal cortex, posterior cingulate cortex, and hippocampus—are summarized in Table 1. Advanced neuroimaging studies increasingly support the idea that MTT and insight rely on overlapping brain networks (DMN) (Østby et al., Reference Østby, Walhovd, Tamnes, Grydeland, Westlye and Fjell2012; Viard et al., Reference Viard, Chételat, Lebreton, Desgranges, Landeau, de La Sayette and Piolino2011). Moving beyond traditional univariate contrasts, multivariate fMRI methods such as spatial independent component analysis (sICA) show that seemingly different tasks – like episodic recall, future simulation, and self-appraisal – activate common functional networks (Xu et al., Reference Xu, Calhoun, Worhunsky, Xiang, Li, Wall and Potenza2015). These shared networks often involve the medial prefrontal cortex, posterior cingulate cortex, and hippocampus, where the same brain regions show synchronized activation patterns across task types (Dafni-Merom et al., Reference Dafni-Merom, Monsa, Benbaji, Klein and Arzy2024).
Table 1. Core brain regions shared by mental time travel (MTT) and insight in schizophrenia. These three regions – part of the default mode network – are consistently implicated in both autobiographical memory processes and self-reflective functions. Their disruption may underlie the co-occurring deficits in MTT and illness awareness observed in schizophrenia

Dynamic connectivity studies (‘connectotyping’) show that connections among fronto-hippocampal and default-mode regions reconfigure on the order of seconds as people move through different task stages, rather than remaining static (Miranda-Dominguez et al., Reference Miranda-Dominguez, Mills, Carpenter, Grant, Kroenke, Nigg and Fair2014; Vazquez-Trejo et al., Reference Vazquez-Trejo, Nardos, Schlaggar, Fair and Miranda-Dominguez2022). Time-resolved approaches capture brief, recurring interaction ‘states,’ highlighting flexible adaptation of network coupling to cognitive demands. This rapid reconfiguration is particularly relevant for fronto-hippocampal communication that supports self-referential processing, episodic retrieval, and prospection (Campbell et al., Reference Campbell, Madore, Benoit, Thakral and Schacter2018; Molnar-Szakacs & Uddin, Reference Molnar-Szakacs and Uddin2013). In schizophrenia, multiple studies report altered dynamic functional connectivity – reduced time in highly integrated states, longer dwell in weakly connected states, and fewer state transitions – patterns linked to symptom burden and cognitive dysfunction; such instability plausibly undermines metacognitive operations and clinical insight that depend on fluid shifts between internal mentation and external task focus (Lysaker et al., Reference Lysaker, Gagen, Wright, Vohs, Kukla, Yanos and Hasson-Ohayon2019; Sendi et al., Reference Sendi, Zendehrouh, Ellis, Liang, Fu, Mathalon and Calhoun2021; Shan et al., Reference Shan, Liao, Ou, Ding, Liu, Chen and He2020; Weber et al., Reference Weber, Johnsen, Kroken, Løberg, Kandilarova, Stoyanov and Hugdahl2020; You et al., Reference You, Luo, Yao, Zhao, Li, Wang and Li2022).
Other methods, such as non-negative matrix factorization (NMF), isolate partially overlapping brain networks and can support multivariate decoding of task states. These network patterns have even been used to classify what a person is doing – for example, constructing a mental scene, evaluating personal traits, or making a simple decision (Aggarwal & Gupta, Reference Aggarwal and Gupta2018; Anderson et al., Reference Anderson, Douglas, Kerr, Haynes, Yuille, Xie and Cohen2014; Shirer et al., Reference Shirer, Ryali, Rykhlevskaia, Menon and Greicius2012). Importantly, ventromedial prefrontal and frontoparietal regions often carry high weights in both MTT and insight-related tasks, suggesting that these domains rely on shared control/default-adjacent components (Aggarwal & Gupta, Reference Aggarwal and Gupta2018; Anderson et al., Reference Anderson, Douglas, Kerr, Haynes, Yuille, Xie and Cohen2014; Cole et al., Reference Cole, Reynolds, Power, Repovs, Anticevic and Braver2013; Vincent et al., Reference Vincent, Kahn, Snyder, Raichle and Buckner2008). Here, ‘insight-related tasks’ refer to self-/other trait-judgment paradigms linked to SAI-E/BCIS, reality/source-monitoring with confidence reports, error-awareness paradigms (ACC-mediated), and probabilistic ‘jumping-to-conclusions’ tasks, each recruiting vmPFC and frontoparietal control circuitry (Andreou et al., Reference Andreou, Steinmann, Leicht, Kolbeck, Moritz and Mulert2018; Bedford et al., Reference Bedford, Surguladze, Giampietro, Brammer and David2012; Carter, MacDonald III, Ross, & Stenger, Reference Carter, MacDonald, Ross and Stenger2001; Garrison, Fernandez-Egea, Zaman, Agius, & Simons, Reference Garrison, Fernandez-Egea, Zaman, Agius and Simons2017; Hester, Nestor, & Garavan, Reference Hester, Nestor and Garavan2009; Simons, Garrison, & Johnson, Reference Simons, Garrison and Johnson2017; van der Meer et al., Reference van der Meer, de Vos, Stiekema, Pijnenborg, van Tol, Nolen and Aleman2013). Large-scale analyses pooling data across many task paradigms (8 or more) consistently point to the frontoparietal control network as a key integrative hub. Activity in this network predicts performance in tasks requiring episodic future thinking, autobiographical memory, and clinical insight (Albouy, Martinez-Moreno, Hoyer, Zatorre, & Baillet, Reference Albouy, Martinez-Moreno, Hoyer, Zatorre and Baillet2022; Pagnotta, Riddle, & D’Esposito, Reference Pagnotta, Riddle and D’Esposito2024; Vanasse et al., Reference Vanasse, Fox, Fox, Cauda, Costa, Smith and Lancaster2021). Some researchers note that traditional GLM-based fMRI analyses may miss this overlap, because they average out rapid shifts in connectivity that multivariate methods are better equipped to detect (Fang, Poskanzer, & Anzellotti, Reference Fang, Poskanzer and Anzellotti2023; Moeller & Habeck, Reference Moeller and Habeck2006; Salvador et al., Reference Salvador, Verdolini, Garcia-Ruiz, Jiménez, Sarró, Vilella and Voineskos2020). Taken together, these findings support the idea that MTT and insight do not rely on separate, isolated brain systems. Instead, they draw on a partially overlapping and dynamically coordinated neural architecture (Brocas & Carrillo, Reference Brocas and Carrillo2018; Dafni-Merom et al., Reference Dafni-Merom, Monsa, Benbaji, Klein and Arzy2024; Gauthier & van Wassenhove, Reference Gauthier and van Wassenhove2016).
Resting-state connectivity: trait-level links between network integrity, MTT, and insight
Schizophrenia is reliably associated with altered connectivity within the DMN, most notably reduced (hypo-)connectivity between the vmPFC and the PCC (Dong et al., Reference Dong, Wang, Chang, Luo and Yao2018; Peng et al., Reference Peng, Zhang, Zhou, Song, Yang, Hao and Zhang2021), as well as between the PCC and the hippocampus (Dugré et al., Reference Dugré, Dumais, Tikasz, Mendrek and Potvin2021). Meta-analyses estimate these disruptions to be moderate in magnitude (Cohen’s d ≈ 0.4–0.6). At the same time, early or prodromal findings are heterogeneous: while many reports emphasize hypoconnectivity, some studies in CHR/early-course samples describe increased vmPFC–PCC connectivity (hyperconnectivity), particularly among individuals with poorer clinical insight (Clark et al., Reference Clark, Mittal, Bernard, Ahmadi, King and Turner2018; O’Neill, Mechelli, & Bhattacharyya, Reference O’Neill, Mechelli and Bhattacharyya2019), whereas other early-onset cohorts show reductions (e.g., Hilland et al., Reference Hilland, Johannessen, Jonassen, Alnæs, Jørgensen, Barth, Andreou, Nerland, Wortinger, Smelror, Wedervang-Resell, Bohman, Lundberg, Westlye, Andreassen, Jönsson and Agartz2022) Accordingly, the literature search was broadened to include clinical high-risk (CHR)/ultra-high-risk (UHR) and first-episode cohorts; stage and analytic choices (e.g., global signal regression, parcellation, motion handling) likely moderate the direction of observed DMN effects. These DMN connectivity abnormalities are thought to underlie impairments in self-referential processing, autobiographical memory, and metacognition observed in schizophrenia.
Crucially, the weaker these connections, the fewer episodic details patients recall during the Autobiographical Interview, and the lower their clinical insight, as measured by SUMD scores (Fan et al., Reference Fan, Tan, Huang, Chen, Fan, Wang and Tan2022). Connectivity between the anterior hippocampus and vmPFC is especially important: reduced coupling in this pathway predicts both less vivid future-event construction and lower self-reflectiveness on the BCIS.
In addition, graph-theory studies show reduced global efficiency and weaker hub integrity across the DMN and frontoparietal control networks. These network-level disruptions explain unique variance in SAI-E insight scores – even after accounting for symptom severity (Blessing et al., Reference Blessing, Murty, Zeng, Wang, Davachi and Goff2020; Du et al., Reference Du, Pearlson, Yu, He, Lin, Sui, Wu and Calhoun2016; Dugré et al., Reference Dugré, Dumais, Tikasz, Mendrek and Potvin2021; Livingston et al., Reference Livingston, Kiemes, O’Daly, Knight, Lukow, Jelen and Modinos2024; Micheloyannis, Reference Micheloyannis2012; Pan et al., Reference Pan, Liu, Xue, Sheng, Cai, Cheng and Chen2022).
Dynamic connectivity analyses add a time-based perspective. Patients spend less time in a brain state dominated by DMN and control-network activity, and more time in a sensorimotor-dominated state. Notably, shorter ‘high-DMN’ dwell time predicts both poorer future-event fluency and lower insight 6 months later (Du et al., Reference Du, Pearlson, Yu, He, Lin, Sui, Wu and Calhoun2016; Fox et al., Reference Fox, Abram, Reilly, Eack, Goldman, Csernansky and Smith2017; Sendi et al., Reference Sendi, Zendehrouh, Ellis, Liang, Fu, Mathalon and Calhoun2021).
Together, these resting-state findings mirror task-based deficits. They suggest that predominantly weakened connectivity among the vmPFC, precuneus, and hippocampus, while accommodating early-stage reports of hyperconnectivity, disrupts the flow of episodic content into metacognitive systems, ultimately degrading clinical insight (Fornara et al., Reference Fornara, Papagno and Berlingeri2017; Gee et al., Reference Gee, Dazzan, Grace and Modinos2025; Kühn & Gallinat, Reference Kühn and Gallinat2013).
Electrophysiology: millisecond-scale evidence for a predictive-processing link
EEG studies show that insight failures in schizophrenia begin within milliseconds of processing information. Reduced error-related negativity (ERN) in the medial frontal cortex and lower mismatch negativity (MMN) – both markers of disrupted predictive coding – are linked to fewer episodic memory details and poorer clinical insight (higher SUMD scores) (Hamilton, Boos, & Mathalon, Reference Hamilton, Boos and Mathalon2020; Kansal, Patriciu, & Kiang, Reference Kansal, Patriciu and Kiang2014; Perrottelli et al., Reference Perrottelli, Giordano, Brando, Giuliani, Pezzella, Mucci and Galderisi2022). Additionally, a smaller P300 response to self-relevant cues is associated with lower self-reflectiveness on the BCIS. Together, these findings suggest that weak early brain signals related to prediction errors and salience detection deprive metacognitive systems of the moment-by-moment input needed for vivid mental scene construction – ultimately contributing to impaired insight (Lysaker et al., Reference Lysaker, Gagen, Wright, Vohs, Kukla, Yanos and Hasson-Ohayon2019; Lysaker, Pattison, et al., Reference Lysaker, Pattison, Leonhardt, Phelps and Vohs2018). Electrophysiological findings suggest that fast, early brain signals involved in prediction and self-relevance processing are weakened in schizophrenia, contributing to poor memory detail and impaired insight. Importantly, EEG/magnetoencephalography (MEG) studies of mental time travel show that constructing past and future events elicits a parietal late positive component and late frontal monitoring effects, and engages hippocampal–vmPFC theta interactions; these millisecond-scale signatures track episodic detail and temporal distance (Barry, Barnes, Clark, & Maguire, Reference Barry, Barnes, Clark and Maguire2019; Colás-Blanco, Mioche, La Corte, & Piolino, Reference Colás-Blanco, Mioche, La Corte and Piolino2022; Monk, Barnes, & Maguire, Reference Monk, Barnes and Maguire2020).
Multimodal & molecular imaging: converging structural evidence
Findings from structural MRI, diffusion tensor imaging (DTI), and PET all support the same hippocampal–vmPFC circuit implicated in fMRI and EEG studies. Smaller volumes in the anterior hippocampus and ventromedial prefrontal cortex (vmPFC) are linked to both fewer autobiographical memory details and poorer insight (effect sizes d ≈ 0.4–0.5) (Adriano, Caltagirone, & Spalletta, Reference Adriano, Caltagirone and Spalletta2012; Duan et al., Reference Duan, He, Ou, Wang, Xiao, Li and Chen2020; Dugré et al., Reference Dugré, Dumais, Tikasz, Mendrek and Potvin2021). In addition, reduced fractional anisotropy in the uncinate fasciculus – the main white-matter tract connecting the anterior hippocampus and vmPFC – has been shown to partially mediate the relationship between mental time travel abilities and clinical insight (Herold et al., Reference Herold, Lässer, Schmid, Seidl, Kong, Fellhauer and Schröder2013; Kelly et al., Reference Kelly, Jahanshad, Zalesky, Kochunov, Agartz, Alloza and Donohoe2018; Lysaker & Dimaggio, Reference Lysaker and Dimaggio2014; Samartzis, Dima, Fusar-Poli, & Kyriakopoulos, Reference Samartzis, Dima, Fusar-Poli and Kyriakopoulos2014; Von Der Heide, Skipper, Klobusicky, & Olson, Reference Von Der Heide, Skipper, Klobusicky and Olson2013). This supports a structural basis for failures in integrating episodic memory content into metacognitive awareness.
Taken together, these findings suggest that a structurally and chemically weakened hippocampal–vmPFC loop acts as a ‘hardware bottleneck’ through which impoverished MTT content reaches the systems responsible for self-reflection and insight (Lysaker & Dimaggio, Reference Lysaker and Dimaggio2014; McCormick, Ciaramelli, De Luca, & Maguire, Reference McCormick, Ciaramelli, De Luca and Maguire2018). However, longitudinal multimodal studies that incorporate explicit MTT tasks are still needed to confirm the direction and specificity of this circuit’s role in insight.
Mechanistic & translational implications
A predictive-processing framework best explains the converging evidence: a structurally and neurochemically weakened hippocampal–vmPFC circuit produces low-precision episodic priors, weakens early prediction-error signals (MMN/ERN), and deprives metacognitive systems of the rich autobiographical input needed for self-evaluation – leading to poor clinical insight (Erickson, Ruffle, & Gold, Reference Erickson, Ruffle and Gold2016; Kelly et al., Reference Kelly, Jahanshad, Zalesky, Kochunov, Agartz, Alloza and Donohoe2018; McCormick et al., Reference McCormick, Ciaramelli, De Luca and Maguire2018). PET studies suggest that reduced dopamine synthesis in the vmPFC and excess glutamate in the hippocampus may further reduce the precision of these priors, reinforcing delusional conviction and negative-symptom inertia (Egerton, Modinos, Ferrera, & McGuire, Reference Egerton, Modinos, Ferrera and McGuire2017; Slifstein et al., Reference Slifstein, van de Giessen, Van Snellenberg, Thompson, Narendran, Gil and Abi-Dargham2015). Translationally, two intervention levers emerge: (i) sharpen episodic specificity via episodic-future-thinking drills, memory-specificity training, or VR ‘future-self’ modules; (ii) enhance metacognitive mastery through Metacognitive Reflection and Insight Therapy (MERIT) or insight-focused CBT add-ons (Hasson-Ohayon et al., Reference Hasson-Ohayon, Igra, Lavi-Rotenberg, Goldzweig and Lysaker2024; Ye et al., Reference Ye, Ding, Cui, Liu, Jia, Qin and Wang2022). Pilot RCTs combining these components yield medium effect-size improvements on BCIS and SAI-E, with the strongest gains in highly delusional or trauma-exposed subgroups (López-Morínigo et al., Reference López-Morínigo, Martínez, Barrigón, Escobedo-Aedo, Ruiz-Ruano, Sánchez-Alonso and David2023). Future trials should stratify by trauma and symptom profile, incorporate pre-/post-MTT tasks plus vmPFC–hippocampal rs-fMRI, and test precision-boosting pharmacological adjuncts (e.g., low-dose d-cycloserine, vortioxetine) (Diminich et al., Reference Diminich, Dickerson, Bello, Cather, Kingdon, Rakhshan Rouhakhtar and Goff2020; Redaelli et al., Reference Redaelli, Porffy, Oloyede, Dzahini, Lewis, Lobo and Shergill2022).
Clinical implications and future directions
This model has important implications for both clinical practice and future research. By highlighting the role of impaired MTT and metacognition in the emergence of poor insight, it reframes insight not merely as a fixed symptom but as a dynamic cognitive process that may be amenable to intervention. Clinically, early screening for deficits in autobiographical memory, future simulation, or self-reflective reasoning could help identify patients at risk for persistent insight impairment – particularly in early-course or high-risk populations.
Integrating both cognitive and neural measures – such as scene-construction tasks, BCIS scores, and vmPFC–hippocampal connectivity – may enable more personalized treatment planning. Future research should prioritize longitudinal, stratified trials that test combined cognitive-metacognitive interventions, monitor insight changes over time, and evaluate the utility of MTT-based paradigms as prognostic biomarkers for insight recovery. Ultimately, targeting the MTT–metacognition–insight pathway may enhance engagement, adherence, and long-term functional outcomes in individuals with schizophrenia.
Limitations and conclusion
While this review offers a unified model linking MTT, metacognition, and clinical insight in schizophrenia, several limitations should be noted. Importantly, almost all existing evidence is cross-sectional in nature, making it difficult to determine causal relationships. It remains unclear whether impaired MTT leads to poor insight, whether the reverse is true, or whether both stem from shared disruptions in neural systems like the default mode network. Reverse causality and bidirectional effects are plausible and represent important open questions.
Additionally, the wide variation in how MTT and insight are measured – across both behavioral and neuroimaging studies – limits direct comparisons and meta-analytic synthesis. Insight is often assessed using clinician ratings, which may not fully capture subjective, fluctuating, or motivational aspects of self-awareness.
Moreover, few studies have tested full mediation models that simultaneously assess MTT, metacognition, and insight in the same population, limiting mechanistic understanding. Important moderators such as trauma exposure, symptom subtype, and medication effects are often underreported, despite evidence that they shape both cognitive and neural outcomes. Finally, although structural, functional, and molecular imaging findings broadly converge, truly integrated multimodal studies that link these domains in individual patients remain scarce.
Despite these gaps, the available data support a promising mechanistic framework: that impoverished MTT appears to limit the episodic content available to metacognitive systems, weakening self-reflection and ultimately degrading insight. This pathway is supported by converging evidence from fMRI, EEG, structural imaging, and behavioral tasks. Clinically, targeting both episodic specificity and metacognitive mastery – through cognitive drills, metacognitive therapy, and precision-enhancing pharmacological agents – may improve insight and long-term outcomes in schizophrenia. However, prospective longitudinal and stratified trials remain critically needed to validate this model, clarify causality, and establish whether MTT-based measures can serve as cognitive biomarkers or therapeutic targets for insight recovery.
Funding statement
This research received no specific grant from any funding agency, commercial or not-for-profit sectors.
Competing interests
The author declares none.
Ethical standard
This article does not contain any studies with human participants or animals performed by the author.
